Re:Soluble ACE2 shows promise for treating severe Covid19
by sradman on Friday November 06, 2020 @01:12PM
(#25009750)
I too tried to follow the progress of Apeiron's APN01 which started to get news coverage at the end of February due to a University of British Columbia press release [1]. This pre-existing therapeutic was created out of SARS-CoV-1 research and I expected a SARS-CoV-2 trial to be accelerated. It never happened.
There is a story to be told here. Either a missed opportunity, incompetence, or a complete misunderstanding on my part of what a promising COVID-19 therapeutic looks like.
[1] https://www.med.ubc.ca/news/pilot-clinical-trial-in-china-to...
Here's a great breakdown of how it works by the founder of Apeiron, Dr Joseph Penninger, from March. https://www.youtube.com/watch?v=jAW6VBWTiAA
It has been since discovered that there are other receptors/pathways too for SARS-CoV-2 to enter the cell, but it's still unclear which ones are the main culprits.
https://theconversation.com/a-second-pathway-into-cells-for-...